Anderson W F, Killos L, Sanders-Haigh L, Kretschmer P J, Diacumakos E G
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5399-403. doi: 10.1073/pnas.77.9.5399.
A mixture of two recombinant plasmids was microinjected into mouse thymidine kinase-negative fibroblasts (L cells). One plasmid contained the thymidine kinase gene of herpes simplex virus type I and the other contained the human beta globin gene. Seven fibroblast colonies arising from injected cells incubated in hypoxanthine/aminopterin/thymidine medium were analyzed. These microinjected cells were shown to: (i) produce functionally active herpes simplex type I thymidine kinase enzyme, (ii) replicate the human beta globin gene, and (iii) produce human beta globin mRNA sequences at low levels. Thus, the genetic defect (lack of thymidine kinase activity) was corrected by the microinjected thymidine kinase gene, and a coinjected human beta globin gene was replicated and weakly expressed.
将两种重组质粒的混合物显微注射到小鼠胸苷激酶阴性成纤维细胞(L细胞)中。一种质粒含有单纯疱疹病毒I型的胸苷激酶基因,另一种含有人类β珠蛋白基因。对在次黄嘌呤/氨基蝶呤/胸腺嘧啶核苷培养基中培养的注射细胞产生的七个成纤维细胞集落进行了分析。结果显示,这些显微注射的细胞能够:(i)产生功能活性的单纯疱疹病毒I型胸苷激酶酶,(ii)复制人类β珠蛋白基因,以及(iii)低水平产生人类β珠蛋白mRNA序列。因此,显微注射的胸苷激酶基因纠正了遗传缺陷(缺乏胸苷激酶活性),并且共注射的人类β珠蛋白基因得以复制并弱表达。